Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 1, 2010, Pages

  Huang, Mao Liang ^a,b   Li, Xu ^a   Meng, Ying ^a   Xiao, Bing ^a   Ma, Qiang ^a   Ying, Song Song ^a   Wu, Ping Sheng ^a   Zhang, Zhen Shu ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Fujian Provincial Dermatology Hospital   (China)

Author keywords

Angiotensin converting enzyme 2; Angiotensin converting enzyme inhibitor; Liver fibrosis; Renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; CARBON TETRACHLORIDE; CONNECTIVE TISSUE GROWTH FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MESSENGER RNA; PERINDOPRIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME INDUCTION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER FIBROSIS; LIVER INJURY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; DRUG INTERACTIONS; HEPATIC STELLATE CELLS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PERINDOPRIL; PROTO-ONCOGENE PROTEINS; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; UP-REGULATION;

EID: 74049134978     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05302.x     Document Type: Article

References (29)

1. Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, Angus PW. Upregulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 2002 123 : 1667 1676.
2. Bataller R, Gäbele E, Parsons CJ et al. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology 2005 41 : 1046 1055.
3. Yoshiji H, Noguchi R, Ikenaka Y et al. Renin-angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Curr. Med. Chem. 2007 14 : 2749 2754.
4. Töx U, Steffen HM. Impact of inhibitors of the renin-angiotensin-aldosterone system on liver fibrosis and portal hypertension. Curr. Med. Chem. 2006 13 : 3649 3661.
5. Santos RA, Ferreira AJ, Simões E, Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis. Exp. Physiol. 2008 93 : 519 527.
6. Polizio AH, Gironacci MM, Tomaro ML, Peña C. Angiotensin-(1-7) blocks the angiotensin II-stimulated superoxide production. Pharmacol. Res. 2007 56 : 86 90.
7. Paizis G, Tikellis C, Cooper ME et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005 54 : 1790 1796.
8. Herath CB, Warner FJ, Lubel JS et al. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J. Hepatol. 2007 47 : 387 395.
9. Pereira RM, Dos Santos RA, Teixeira MM et al. The renin-angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of angiotensin-(1-7). J. Hepatol. 2007 46 : 674 681.
10. Donoghue M, Hsieh F, Baronas E et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 2000 87 : E1 9.
11. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000 275 : 33238 33243.
12. Ferrario CM, Jessup J, Chappell MC et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005 111 : 2605 2610.
13. Ferrario CM, Jessup J, Gallagher PE et al. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int. 2005 68 : 2189 2196.
14. Burchill L, Velkoska E, Dean RG et al. Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression. Exp. Physiol. 2008 93 : 622 630.
15. Ocaranza MP, Godoy I, Jalil JE et al. Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension 2006 48 : 572 578.
16. 4-induced rat hepatic fibrogenesis by inhibiting TGF-β1, PDGF-BB, NF-κB and MMP-2,9. World J. Gastroenterol. 2005 31 : 4807 4811.
17. Li X, Meng Y, Wu P, Zhang Z, Yang X. Angiotensin II and aldosterone stimulating NF-κB and AP-1 activation in hepatic fibrosis of rat. Regul. Pept. 2007 138 : 15 25.
18. Simões e Silva AC, Pinheiro SV, Pereira RM, Ferreira AJ, Santos RA. The therapeutic potential of angiotensin-(1-7) as a novel renin-angiotensin system mediator. Mini-Rev. Med. Chem. 2006 6 : 603 609.
19. Grobe JL, Mecca AP, Mao H, Katovich MJ. Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am. J. Physiol. Heart Circ. Physiol. 2006 290 : H2417 23.
20. 1-ERK/p38 MAP kinase pathway. Am. J. Pathol. 2008 172 : 1174 1183.
21. Gallagher PE, Chappell MC, Ferrario CM, Tallant EA. Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am. J. Physiol. Cell Physiol. 2006 290 : C420 6.
22. Rivière G, Michaud A, Breton C et al. Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat. Hypertension 2005 46 : 1169 1174.
23. 2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-alpha knock-out mice. Exp. Physiol. 2008 93 : 658 664.
24. Ferreira AJ, Santos RA. Cardiovascular actions of angiotensin-(1-7). Braz. J. Med. Biol. Res. 2005 38 : 499 507.
25. Ferrario CM, Iyer SN. Angiotensin-(1-7): A bioactive fragment of the renin-angiotensin system. Regul. Pept. 1998 78 : 13 18.
26. Hamming I, van Goor H, Turner AJ et al. Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats. Exp. Physiol. 2008 93 : 631 638.
27. Sharman DC, Morris AD, Struthers AD. Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus. Diabetologia 2007 50 : 2061 2066.
28. Lambert DW, Hooper NM, Turner AJ. Angiotensin-converting enzyme 2 and new insights into the renin-angiotensin system. Biochem. Pharmacol. 2008 75 : 781 786.
29. Gressner OA, Gressner AM. Connective tissue growth factor: A fibrogenic master switch in fibrotic liver diseases. Liver Int. 2008 28 : 1065 1079.